Liver AE leads to withdrawal of Exanta

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1089, 2006-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Melagatran: Exanta, H 319/68

Drugs in R&D, Vol. 3, Iss. 6, 2002-01 ,pp. : 421-425

Adis International

Access to resources Recommend Favorite

Erythropoietin Withdrawal Leads to the Destruction of Young Red Cells at the Endothelial-Macrophage Interface

Current Pharmaceutical Design, Vol. 10, Iss. 2, 2004-01 ,pp. : 183-190

Bentham Science Publishers

Access to resources Recommend Favorite

Azathioprine withdrawal: Liver transplant rejection, cholestasis and hepatitis: case report

Reactions Weekly, Vol. 1, Iss. 1410, 2012-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Ximelagatran: Exanta, H 376, H 376/95, H 37695

Drugs in R&D, Vol. 3, Iss. 6, 2002-01 ,pp. : 431-434

Adis International

Access to resources Recommend Favorite

Azathioprine/infliximab/prednisone withdrawal: Reactivation of hepatitis B and fatal liver failure: case report

Reactions Weekly, Vol. 1, Iss. 1185, 2008-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite